| Name |
Apremilast STADA 30 mg filmom obložene tablete |
| Marketing Authorisation Number |
HR-H-623526585 |
| Active Substance |
apremilast |
| Composition |
jedna filmom obložena tableta sadrži 30 mg apremilasta |
| Pharmaceutical Form |
Filmom obložena tableta |
| Manufacturer |
STADA Arzneimittel AG, Bad Vilbel, Njemačka |
| Marketing Authorisation Holder |
Stada d.o.o., Hercegovačka 14, Zagreb, Hrvatska |
| Marketing Authorisation Date |
03.10.2024 |
| MA Period of Validity |
03.10.2029 |
| Classification Number |
UP/I-530-09/23-01/16 |
| Registration Number |
381-12-01/70-24-09 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product subject to restricted medical prescription
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
L04AA32 |
| Marketing status |
Marketed |
| Shortage status |
No shortage |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
| Summary of risk management plan |
download |
